BWM
BDTX icon

Brown Wealth Management’s Black Diamond Therapeutics BDTX Stock Holding History

Brown Wealth Management’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,932
Closed -$79.3K – 111
2025
Q3 		$79.3K Sell
20,932
-79,068
-79% -$231K 0.02% 99
2025
Q2 		$248K Hold
100,000
– – 0.08% 88
2025
Q1 		$155K Buy
+100,000
New +$210K 0.05% 92

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Wealth Management's BDTX Position: Q4 2025 in Review

Brown Wealth Management sold out of Black Diamond Therapeutics (BDTX) in Q4 2025, closing a stake of 20,932 shares — an estimated $79.3K sold.

Brown Wealth Management first reported a position in BDTX in Q1 2025 and held it in 3 quarters. The position peaked at $248K in Q2 2025. 104 funds tracked by Wall St. Rank hold BDTX as of Q4 2025.

  • Brown Wealth Management reported no remaining Black Diamond Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Brown Wealth Management sold 20,932 Black Diamond Therapeutics shares in Q4 2025, an estimated $79.3K.
  • Brown Wealth Management first reported a position in Black Diamond Therapeutics in Q1 2025 and held it in 3 quarters.
  • Brown Wealth Management's Black Diamond Therapeutics position peaked at $248K in Q2 2025.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q4 2025.

Based on Brown Wealth Management's 13F filing for Q4 2025, filed 6 Feb 2026.